GERM CELL TUMOURS OF THE OVARY IN CHILDREN AND ADOLESCENTS: A CLINICAL STUDY OF 109 PATIENTS IN A SPECIALIZED CANCER CENTRE
Abstract
Objective: Paediatric ovarian germ cell tumours (GCTs) are rare tumours with
malignant tumours extremely rare.
Methods: All the paediatric patients who received treatment for histology proven ovarian GCT at Shaukat Khanum Memorial Cancer Hospital from January 2006 to December 2014 were retrospectively reviewed. Patients over the age of 18 years were excluded from the study. A total of 109 patients were included in the study. A set of parameters were identified to record initial clinical presentation and examination, imaging and laboratory investigations including tumour marker levels. Decisions of multidisciplinary team meetings, surgical treatment, neo adjuvant, adjuvant chemotherapy and radiation data retrieved. Data analysiscarried out using SPSS 20.
Results: In total 109 girls presented to our hospital during the study period, most of them above the age of 5 years, with dysgerminoma being the most common followed by yolk sac tumour. Most of the patients received treatment outside our hospital and were referred here for chemoradiotherapy. Fertility preserving surgery was the most commonly performed surgical procedure with a mean follow-up of 50.4 months and >75% overall 5-year survival.
Conclusion: Regardless of histologic types, the outcomes of GCT can be improved with a multidisciplinary approach.
Key words: Dysgerminomas, germ cell tumours, ovarian tumours
References
Poynter JN, Amatruda JF, Ross JA. Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer 2010;116:4882-91.
Rescorla F. Paediatric germ cell tumours. Semin Surg Oncol 1999;16:144-58.
Baade PD, Youlden DR, Valery PC, et al. Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer 2010;102:620-6.
Schneider DT, Calaminus G, Koch S, et al. Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 2004;42:169-75.
Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010;36:277-85.
Fresneau B, Orbach D, Faure-Conter C, et al. Sex-cord stromal tumors in children and teenagers: Results of the TGM-95 study. Pediatr Blood Cancer 2015;62:2114-9.
Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005;97:519-23.
Cecchetto G, Ferrari A, Bernini G, et al. Sex cord stromal tumors of the ovary in children: A clinicopathological report from the Italian TREP project. Pediatr Blood Cancer 2011;56:1062-7.
Schneider DT, Calaminus G, Wessalowski R, et al. Ovarian sex cord-stromal tumours in children and adolescents. J Clin Oncol 2003;21:2357-63.
Lee IH, Choi CH, Hong DG, et al. Clinicopathologic characteristics of granulosa cell tumors of the ovary: A multicenter retrospective study. J Gynecol Oncol 2011;22:188-95.
Billmire D, Vinocur C, Rescorla F, et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: An intergroup study. J Pediatr Surg 2004;39:424-9.
Al Jama FE, Al Ghamdi AA, Gasim T, et al. Ovarian tumors in children and adolescents a clinical study of 52 patients in a university hospital. J Pediatr Adolesc Gynecol 2011;24:25-8.
Pauniaho SL, Salonen J, Helminen M, et al. Germ cell tumors in children and adolescents in Finland: Trends over 1969-2008. Cancer Causes Control 2014;25:1337-41.
Marina NM, Cushing B, Giller R, et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A pediatric oncology group/Children’s cancer group intergroup study.J Clin Oncol 1999;17:2137-43.
Billmire DF, Cullen JW, Rescorla FJ, et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: Report from the children’s oncology group. J Clin Oncol 2014;32:465-70.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.
Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.
